The key to longitudinal patient journeys
A data-rich longitudinal patient journey is key to research and development, commercialization and...
A data-rich longitudinal patient journey is key to research and development, commercialization and...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
Building a modern data infrastructure within today’s healthcare enterprise is challenging on many...
The COVID-19 outbreak has created an unprecedented need for real-time data. As the global pandemic...
Healthcare has the lowest digital ad spend among major industries today. Privacy protection laws...
Complex medical treatments like gene and immunotherapies have brought us into a new era of...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists trea...